首页> 美国卫生研究院文献>The EMBO Journal >Mr 46,000 mannose 6-phosphate specific receptor: its role in targeting of lysosomal enzymes.
【2h】

Mr 46,000 mannose 6-phosphate specific receptor: its role in targeting of lysosomal enzymes.

机译:先生46,000甘露糖6磷酸特异受体:其在靶向溶酶体酶中的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antibodies that block the ligand binding site of the cation-dependent mannose 6-phosphate specific receptor (Mr 46,000 MPR) were used to probe the function of the receptor in transport of lysosomal enzymes. Addition of the antibodies to the medium of Morris hepatoma 7777 cells, which express only the Mr 46,000 MPR, resulted in a decreased intracellular retention and increased secretion of newly synthesized lysosomal enzymes. In fibroblasts and HepG2 cells that express the cation-independent mannose 6-phosphate specific receptor (Mr 215,000 MPR) in addition to the Mr 46,000 MPR, antibodies against the Mr 46,000 MPR inhibited the intracellular retention of newly synthesized lysosomal enzymes only when added to the medium together with antibodies against the Mr 215,000 MPR. Morris hepatoma (M.H.) 7777 did not endocytose lysosomal enzymes, while U937 monocytes, which express both types of MPR, internalized lysosomal enzymes. The uptake was inhibited by antibodies against the Mr 215,000 MPR, but not by antibodies against the Mr 46,000 MPR. These observations suggest that Mr 46,000 MPR mediates transport of endogenous but not endocytosis of exogenous lysosomal enzymes. Internalization of receptor antibodies indicated that the failure to mediate endocytosis of lysosomal enzymes is due to an inability of surface Mr 46,000 MPR to bind ligands rather than its exclusion from the plasma membrane or from internalization.
机译:阻断阳离子依赖性甘露糖6-磷酸特异性受体(Mr 46,000 MPR)配体结合位点的抗体被用来探测受体在溶酶体酶运输中的功能。将抗体添加到仅表达Mr 46,000 MPR的Morris肝癌7777细胞培养基中,会导致细胞内滞留减少和新合成的溶酶体酶的分泌增加。在除了Mr 46,000 MPR之外还表达不依赖于阳离子的甘露糖6-磷酸特异性受体(Mr 215,000 MPR)的成纤维细胞和HepG2细胞中,针对Mr 46,000 MPR的抗体只有将其加入溶酶体酶后才能抑制其在细胞内的滞留。培养基以及针对215,000 MPR先生的抗体。莫里斯肝癌(M.H.)7777没有内吞酶溶酶体酶,而同时表达两种类型MPR的U937单核细胞则内化了溶酶体酶。摄取受到215,000 MPR先生抗体的抑制,但不受46,000 MPR先生抗体的抑制。这些观察结果表明,Mr 46,000 MPR介导了外源溶酶体酶的内源性转运,而不是内吞性转运。受体抗体的内在化表明不能介导溶酶体酶的内吞作用是由于表面46,000 MPR Mr无法结合配体,而不是其从质膜或内在化排斥。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号